Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents




Background


There is currently a paucity of data regarding the clinical outcome of the everolimus-eluting stent (EES) in unselected patients with the whole spectrum of obstructive coronary artery disease as compared to the paclitaxel-eluting stent (PES) and the sirolimus-eluting stent (SES).




Methods


The study cohort comprised 6615 consecutive patients who underwent coronary artery stent implantation with the EES (519), the PES (2036) or the SES (4060) at the Washington Hospital Centre. Patients who received bare-metal stents, the zotarolimus-eluting stent or two different types of drug-eluting stents were excluded. The clinical endpoints analyzed were death, death or Q-wave myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), definite stent thrombosis (ST) and major adverse cardiac events (MACE), defined as the composite of death, Q-wave MI or TLR at 1 year.




Methods


The study cohort comprised 6615 consecutive patients who underwent coronary artery stent implantation with the EES (519), the PES (2036) or the SES (4060) at the Washington Hospital Centre. Patients who received bare-metal stents, the zotarolimus-eluting stent or two different types of drug-eluting stents were excluded. The clinical endpoints analyzed were death, death or Q-wave myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), definite stent thrombosis (ST) and major adverse cardiac events (MACE), defined as the composite of death, Q-wave MI or TLR at 1 year.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Coronary stenting with MGuard: extended follow-up of first human trial
  2. Understanding the impact of drug-eluting stent on vascular function and the nitric oxide pathway genes using a pig coronary artery stent implantation model
  3. Treatment of STEMI with neither PCI nor thrombolysis
  4. Definite stent thrombosis: a 2-center New Zealand registry

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents

Full access? Get Clinical Tree
Get Clinical Tree app for offline access